Pimelic Diphenylamide 106

CAS No. 937039-45-7

Pimelic Diphenylamide 106( RGFA-8 | TC-H 106 | BRD-4657 )

Catalog No. M16712 CAS No. 937039-45-7

A slow, tight-binding inhibitor of class I HDACs.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
10MG 37 In Stock
25MG 65 In Stock
50MG 110 In Stock
100MG 200 In Stock
200MG 296 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Pimelic Diphenylamide 106
  • Note
    Research use only, not for human use.
  • Brief Description
    A slow, tight-binding inhibitor of class I HDACs.
  • Description
    A slow, tight-binding inhibitor of class I HDACs (HDAC1/2/3, Ki=148/102/14 nM respectively); shows weak inhibition on HDAC8 (IC50=5 uM); has preference toward HDAC3.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    RGFA-8 | TC-H 106 | BRD-4657
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    937039-45-7
  • Formula Weight
    339.4314
  • Molecular Formula
    C20H25N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 25 mg/mL
  • SMILES
    O=C(NC1=CC=CC=C1N)CCCCCC(NC2=CC=C(C)C=C2)=O
  • Chemical Name
    Heptanediamide, N1-(2-aminophenyl)-N7-(4-methylphenyl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Chou CJ, et al. J Biol Chem. 2008 Dec 19;283(51):35402-9. 2. Xu C, et al. Chem Biol. 2009 Sep 25;16(9):980-9.
molnova catalog
related products
  • Tasquinimod

    An orally active antiangiogenic agent with anti-prostate cancer activity, an allosteric modulator of HDAC4 with Kd of 10-30 nM.

  • T247

    A potent and selective HDAC3 inhibitor with IC50 of 0.24 uM, >75-fold selectivity over HDAC1 and no activity against HDAC4/6/8.

  • CHR-3996

    CHR-3996 (Nanatinostat, VRx-3996, CHR3996, Tractinostat) is a potent, class I-selective, orally active HDAC inhibitor with IC50 of 3-7 nM for HDAC1/2/3.